School Of Medicine
Consultant Clinical Biochemist & Head of Department of Clinical Biochemistry and Diagnostic Endocrinology in the Mater University Hospital.
I have overseen the development of a specialist laboratory using mass spectrometry (LC-MS/MS) technology which provides services to other hospitals and in some cases, nationally. The developments include plasma metanephrines, androstenedione, testosterone, free cortisol, vitamin D, immunosuppressant drugs and voriconizole.
|Committee : International TF-CKD biomarker committee|
Peer Reviewed Journals
|Fitzgibbon MC, Tormey WP (2094) 'Paediatric reference ranges for urinary catecholamines/metabolites and their relevance in neuroblastoma diagnosis'. Annals of Clinical Biochemistry, 31 ( Pt 1) :1-11. [Details]|
|Fitzgibbon M, FitzGerald RJ;Tormey WP;O'Meara A;Kenny D (2092) 'Reference values for urinary HMMA, HVA, noradrenaline, adrenaline, and dopamine excretion in children using random urine samples and HPLC with electrochemical detection'. Annals of Clinical Biochemistry, 29 ( Pt 4) :400-404. [Details]|
|Stockmann H, Coss KP;Rubio-Gozalbo ME;Knerr I;Fitzgibbon M;Maratha A;Wilson J;Rudd P;Treacy EP (2015) 'IgG N-Glycosylation Galactose Incorporation Ratios for the Monitoring of Classical Galactosaemia'. JIMD reports, . [DOI] [Details]|
|James S, Jhanji S;Smith A;O'Brien G;Fitzgibbon M;Pearse RM (2014) 'Comparison of the prognostic accuracy of scoring systems, cardiopulmonary exercise testing, and plasma biomarkers: a single-centre observational pilot study'. British Journal of Anaesthesia, 112 (3):491-497. [DOI] [Details]|
|Lee GR, Jhanji S;Tarrant H;James S;Pearse RM;Fitzgibbon M (2014) 'Peri-operative troponin monitoring using a prototype high-sensitivity cardiac troponin I (hs-cTnI) assay: comparisons with hs-cTnT and contemporary cTnI assays'. Annals of Clinical Biochemistry, 51 (Pt 2):258-268. [DOI] [Details]|
|Cullen MR, Jhanji S;Pearse RM;Fitzgibbon MC (2014) 'Neutrophil gelatinase-associated lipocalin and albuminuria as predictors of acute kidney injury in patients treated with goal-directed haemodynamic therapy after major abdominal surgery'. Annals of Clinical Biochemistry, 51 (Pt 3):392-399. [DOI] [Details]|
|Roy AK, McCullagh BN;Segurado R;McGorrian C;Keane E;Keaney J;Fitzgibbon MN;Mahon NG;Murray PT;Gaine SP (2014) 'Detection of high-sensitivity troponin in outpatients with stable pulmonary hypertension identifies a subgroup at higher risk of adverse outcomes'. Journal of cardiac failure, 20 (1):31-37. [DOI] [Details]|
|McGorrian CM, Lyster S;Roy A;Tarrant H;Codd M;Doran P;Fitzgibbon M;Galvin J;Mahon NG (2013) 'Use of a highly-sensitive cardiac troponin I assay in a screening population for hypertrophic cardiomyopathy: a case-referent study'. BMC cardiovascular disorders, 13 . [DOI] [Details]|
|Cullen MR, Murray PT;Fitzgibbon MC (2012) 'Establishment of a reference interval for urinary neutrophil gelatinase-associated lipocalin'. Annals of Clinical Biochemistry, 49 (Pt 2):190-193. [DOI] [Details]|
|Fitzgibbon MC, Donnelly M;Phillips JP;Murray P;Moran R;Bouchier-Hayes DJ (2007) 'The evolution of trauma services at Beaumont Hospital'. Irish Journal of Medical Science, 176 (1):15-21. [Details]|
| Translational biomarker research:
I have developed an active research group investigating the clinical utility of novel biomarkers including hsTroponin, ST-2, Cystatin C, NGAL, aldosterone and renin in several disease states including inherited cardiac diseases and cancer.